Parathyroid hormone-related peptide production and action in a myoepithelial cell line derived from normal human breast

Patricia K. Seitz, Kay M. Cooper, Kirk L. Ives, Jin Ishizuka, Courtney Townsend, Srinivasan Rajaraman, Cary W. Cooper

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Physiological roles for PTH-related peptide (PTHrP) appear varied, but remain to be clarified. The peptide is present in large amounts in milk, and PTHrP mRNA has been shown to be present in high amounts in lactating mammary gland. Because PTHrP can cause smooth muscle relaxation, we hypothesized that the peptide might affect the contractility of the breast myoepithelial cell and thereby affect milk ejection. To test this idea, we asked whether PTHrP might affect second messenger responses in a human mammary gland myoepithelial cell line (Hs578Bst) derived originally from normal breast tissue. To verify the presumed origin of these cells, we also examined the effects of oxytocin. Cells were grown in culture in multiwell plates and exposed to test peptides for 15 min in buffer containing 1 mM isobutylme-thylxanthine, and intracellular cAMP was measured by RIA. Both PTHrP-(1-34) and PTH-(1-34) increased cAMP in a dose-related fashion (ED50, 5 nM), with a maximal effect (3-fold) occurring at 100 nM. The ability of PTHrP to stimulate cAMP was inhibited by a 10-to 100-fold molar excess of the specific inhibitors, PTH-(3-34) or PTHrP-(7-34). Inhibitors alone did not alter cAMP. Oxytocin also produced an increase in cAMP, but the effect was inconsistent and occurred only with high doses (0.1-1 μM). Using cells grown on coverslips and loaded with fura-2AM, intracellular Ca2+ was monitored in cells exposed to test peptides. Oxytocin (0.2-20 nM) produced rapid dose-related increases in intracellular Ca2+, with a peak and plateau characteristic of initial mobilization of intracellular Ca2+, followed by entry of extracellular Ca. The plateau was eliminated by the Ca channel antagonist La3+ or by perfusion of cells with Ca-free medium. PTHrP (10-100 nM) altered the intracellular Ca2+ response to oxytocin in 66% of 39 preparations tested. PTHrP inhibited the Ca2+ response when given before oxytocin or transiently decreased the plateau phase of the Ca2+ response when given after oxytocin. Analysis of cellular mRNA using reverse transcription polymerase chain reaction indicated that these cells express the gene for PTHrP, and immunohistochemistry using antiserum to PTHrP revealed positive staining of cells. Measurement of immunoreactive PTHrP in conditioned medium confirmed that these cells can synthesize and secrete the peptide. The finding of a response of this cell line to oxytocin provides functional evidence of their myoepithelial derivation. The facts that the cells produce PTHrP and show cAMP and intracellular Ca2+ responses to PTHrP-(1-34) support the notion that PTHrP may serve an autocrine or paracrine role in the regulation of milk ejection during lactation.

Original languageEnglish (US)
Pages (from-to)1116-1124
Number of pages9
JournalEndocrinology
Volume133
Issue number3
StatePublished - Sep 1993

Fingerprint

Parathyroid Hormone-Related Protein
Breast
Cell Line
Oxytocin
Peptides
Milk Ejection
Human Mammary Glands
Messenger RNA
Muscle Relaxation
Second Messenger Systems
Conditioned Culture Medium
Parathyroid Hormone
Lactation

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Seitz, P. K., Cooper, K. M., Ives, K. L., Ishizuka, J., Townsend, C., Rajaraman, S., & Cooper, C. W. (1993). Parathyroid hormone-related peptide production and action in a myoepithelial cell line derived from normal human breast. Endocrinology, 133(3), 1116-1124.

Parathyroid hormone-related peptide production and action in a myoepithelial cell line derived from normal human breast. / Seitz, Patricia K.; Cooper, Kay M.; Ives, Kirk L.; Ishizuka, Jin; Townsend, Courtney; Rajaraman, Srinivasan; Cooper, Cary W.

In: Endocrinology, Vol. 133, No. 3, 09.1993, p. 1116-1124.

Research output: Contribution to journalArticle

Seitz, PK, Cooper, KM, Ives, KL, Ishizuka, J, Townsend, C, Rajaraman, S & Cooper, CW 1993, 'Parathyroid hormone-related peptide production and action in a myoepithelial cell line derived from normal human breast', Endocrinology, vol. 133, no. 3, pp. 1116-1124.
Seitz, Patricia K. ; Cooper, Kay M. ; Ives, Kirk L. ; Ishizuka, Jin ; Townsend, Courtney ; Rajaraman, Srinivasan ; Cooper, Cary W. / Parathyroid hormone-related peptide production and action in a myoepithelial cell line derived from normal human breast. In: Endocrinology. 1993 ; Vol. 133, No. 3. pp. 1116-1124.
@article{b1c70d164e6240119c91e1a4f979349c,
title = "Parathyroid hormone-related peptide production and action in a myoepithelial cell line derived from normal human breast",
abstract = "Physiological roles for PTH-related peptide (PTHrP) appear varied, but remain to be clarified. The peptide is present in large amounts in milk, and PTHrP mRNA has been shown to be present in high amounts in lactating mammary gland. Because PTHrP can cause smooth muscle relaxation, we hypothesized that the peptide might affect the contractility of the breast myoepithelial cell and thereby affect milk ejection. To test this idea, we asked whether PTHrP might affect second messenger responses in a human mammary gland myoepithelial cell line (Hs578Bst) derived originally from normal breast tissue. To verify the presumed origin of these cells, we also examined the effects of oxytocin. Cells were grown in culture in multiwell plates and exposed to test peptides for 15 min in buffer containing 1 mM isobutylme-thylxanthine, and intracellular cAMP was measured by RIA. Both PTHrP-(1-34) and PTH-(1-34) increased cAMP in a dose-related fashion (ED50, 5 nM), with a maximal effect (3-fold) occurring at 100 nM. The ability of PTHrP to stimulate cAMP was inhibited by a 10-to 100-fold molar excess of the specific inhibitors, PTH-(3-34) or PTHrP-(7-34). Inhibitors alone did not alter cAMP. Oxytocin also produced an increase in cAMP, but the effect was inconsistent and occurred only with high doses (0.1-1 μM). Using cells grown on coverslips and loaded with fura-2AM, intracellular Ca2+ was monitored in cells exposed to test peptides. Oxytocin (0.2-20 nM) produced rapid dose-related increases in intracellular Ca2+, with a peak and plateau characteristic of initial mobilization of intracellular Ca2+, followed by entry of extracellular Ca. The plateau was eliminated by the Ca channel antagonist La3+ or by perfusion of cells with Ca-free medium. PTHrP (10-100 nM) altered the intracellular Ca2+ response to oxytocin in 66{\%} of 39 preparations tested. PTHrP inhibited the Ca2+ response when given before oxytocin or transiently decreased the plateau phase of the Ca2+ response when given after oxytocin. Analysis of cellular mRNA using reverse transcription polymerase chain reaction indicated that these cells express the gene for PTHrP, and immunohistochemistry using antiserum to PTHrP revealed positive staining of cells. Measurement of immunoreactive PTHrP in conditioned medium confirmed that these cells can synthesize and secrete the peptide. The finding of a response of this cell line to oxytocin provides functional evidence of their myoepithelial derivation. The facts that the cells produce PTHrP and show cAMP and intracellular Ca2+ responses to PTHrP-(1-34) support the notion that PTHrP may serve an autocrine or paracrine role in the regulation of milk ejection during lactation.",
author = "Seitz, {Patricia K.} and Cooper, {Kay M.} and Ives, {Kirk L.} and Jin Ishizuka and Courtney Townsend and Srinivasan Rajaraman and Cooper, {Cary W.}",
year = "1993",
month = "9",
language = "English (US)",
volume = "133",
pages = "1116--1124",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Parathyroid hormone-related peptide production and action in a myoepithelial cell line derived from normal human breast

AU - Seitz, Patricia K.

AU - Cooper, Kay M.

AU - Ives, Kirk L.

AU - Ishizuka, Jin

AU - Townsend, Courtney

AU - Rajaraman, Srinivasan

AU - Cooper, Cary W.

PY - 1993/9

Y1 - 1993/9

N2 - Physiological roles for PTH-related peptide (PTHrP) appear varied, but remain to be clarified. The peptide is present in large amounts in milk, and PTHrP mRNA has been shown to be present in high amounts in lactating mammary gland. Because PTHrP can cause smooth muscle relaxation, we hypothesized that the peptide might affect the contractility of the breast myoepithelial cell and thereby affect milk ejection. To test this idea, we asked whether PTHrP might affect second messenger responses in a human mammary gland myoepithelial cell line (Hs578Bst) derived originally from normal breast tissue. To verify the presumed origin of these cells, we also examined the effects of oxytocin. Cells were grown in culture in multiwell plates and exposed to test peptides for 15 min in buffer containing 1 mM isobutylme-thylxanthine, and intracellular cAMP was measured by RIA. Both PTHrP-(1-34) and PTH-(1-34) increased cAMP in a dose-related fashion (ED50, 5 nM), with a maximal effect (3-fold) occurring at 100 nM. The ability of PTHrP to stimulate cAMP was inhibited by a 10-to 100-fold molar excess of the specific inhibitors, PTH-(3-34) or PTHrP-(7-34). Inhibitors alone did not alter cAMP. Oxytocin also produced an increase in cAMP, but the effect was inconsistent and occurred only with high doses (0.1-1 μM). Using cells grown on coverslips and loaded with fura-2AM, intracellular Ca2+ was monitored in cells exposed to test peptides. Oxytocin (0.2-20 nM) produced rapid dose-related increases in intracellular Ca2+, with a peak and plateau characteristic of initial mobilization of intracellular Ca2+, followed by entry of extracellular Ca. The plateau was eliminated by the Ca channel antagonist La3+ or by perfusion of cells with Ca-free medium. PTHrP (10-100 nM) altered the intracellular Ca2+ response to oxytocin in 66% of 39 preparations tested. PTHrP inhibited the Ca2+ response when given before oxytocin or transiently decreased the plateau phase of the Ca2+ response when given after oxytocin. Analysis of cellular mRNA using reverse transcription polymerase chain reaction indicated that these cells express the gene for PTHrP, and immunohistochemistry using antiserum to PTHrP revealed positive staining of cells. Measurement of immunoreactive PTHrP in conditioned medium confirmed that these cells can synthesize and secrete the peptide. The finding of a response of this cell line to oxytocin provides functional evidence of their myoepithelial derivation. The facts that the cells produce PTHrP and show cAMP and intracellular Ca2+ responses to PTHrP-(1-34) support the notion that PTHrP may serve an autocrine or paracrine role in the regulation of milk ejection during lactation.

AB - Physiological roles for PTH-related peptide (PTHrP) appear varied, but remain to be clarified. The peptide is present in large amounts in milk, and PTHrP mRNA has been shown to be present in high amounts in lactating mammary gland. Because PTHrP can cause smooth muscle relaxation, we hypothesized that the peptide might affect the contractility of the breast myoepithelial cell and thereby affect milk ejection. To test this idea, we asked whether PTHrP might affect second messenger responses in a human mammary gland myoepithelial cell line (Hs578Bst) derived originally from normal breast tissue. To verify the presumed origin of these cells, we also examined the effects of oxytocin. Cells were grown in culture in multiwell plates and exposed to test peptides for 15 min in buffer containing 1 mM isobutylme-thylxanthine, and intracellular cAMP was measured by RIA. Both PTHrP-(1-34) and PTH-(1-34) increased cAMP in a dose-related fashion (ED50, 5 nM), with a maximal effect (3-fold) occurring at 100 nM. The ability of PTHrP to stimulate cAMP was inhibited by a 10-to 100-fold molar excess of the specific inhibitors, PTH-(3-34) or PTHrP-(7-34). Inhibitors alone did not alter cAMP. Oxytocin also produced an increase in cAMP, but the effect was inconsistent and occurred only with high doses (0.1-1 μM). Using cells grown on coverslips and loaded with fura-2AM, intracellular Ca2+ was monitored in cells exposed to test peptides. Oxytocin (0.2-20 nM) produced rapid dose-related increases in intracellular Ca2+, with a peak and plateau characteristic of initial mobilization of intracellular Ca2+, followed by entry of extracellular Ca. The plateau was eliminated by the Ca channel antagonist La3+ or by perfusion of cells with Ca-free medium. PTHrP (10-100 nM) altered the intracellular Ca2+ response to oxytocin in 66% of 39 preparations tested. PTHrP inhibited the Ca2+ response when given before oxytocin or transiently decreased the plateau phase of the Ca2+ response when given after oxytocin. Analysis of cellular mRNA using reverse transcription polymerase chain reaction indicated that these cells express the gene for PTHrP, and immunohistochemistry using antiserum to PTHrP revealed positive staining of cells. Measurement of immunoreactive PTHrP in conditioned medium confirmed that these cells can synthesize and secrete the peptide. The finding of a response of this cell line to oxytocin provides functional evidence of their myoepithelial derivation. The facts that the cells produce PTHrP and show cAMP and intracellular Ca2+ responses to PTHrP-(1-34) support the notion that PTHrP may serve an autocrine or paracrine role in the regulation of milk ejection during lactation.

UR - http://www.scopus.com/inward/record.url?scp=0027220137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027220137&partnerID=8YFLogxK

M3 - Article

VL - 133

SP - 1116

EP - 1124

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 3

ER -